2020 annual financial data

Ernexa Therapeutics Inc. 2020 Net margin

Ernexa Therapeutics Inc. 2020 net margin with verified reported values.

Direct answer

Net margin was 205.28%.

Operating income was -7,248,000 USD and net income was 11,906,000 USD.
Operating cash flow was -8,101,000 USD.

Get free Ernexa Therapeutics Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
5,800,000 USD
Operating income
-7,248,000 USD
Net income
11,906,000 USD
Operating cash flow
-8,101,000 USD